Home
About
Overview
Sharing Data
ORCID
Help
History (17)
A possible desensitized state conformation of the human a7 nicotinic receptor: A molecular dynamics study.
SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment.
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Phosphorylation of nucleotide molecules in hydrothermal environments.
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstet Gynecol. 2020 06; 135(6):1313-1326.
View in:
PubMed
subject areas
Adult
Bone Density
Double-Blind Method
Drug Therapy, Combination
Estradiol
Female
Gonadotropin-Releasing Hormone
Headache
Hot Flashes
Humans
Hydrocarbons, Fluorinated
Leiomyoma
Menorrhagia
Middle Aged
Nausea
Norethindrone
Pyrimidines
Quality of Life
Uterine Neoplasms
authors with profiles
Ayman Al-Hendy